United States Reverse Transcriptase Market Report 2016

October 2016 | 120 pages | ID: U25CA63E8B8EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Reverse Transcriptase

Revenue, means the sales value of Reverse Transcriptase

This report studies sales (consumption) of Reverse Transcriptase in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Thermo Fisher Scientific, Inc. (U.S.)
• Merck KGaA (Germany)
• New England Biolabs, Inc. (U.S.)
• Promega (U.S.)
• Illumina, Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• F. Hoffmann-la Roche Ltd. (Switzerland)
• Takara Bio Inc. (Japan)
• QIAGEN N.V. (The Netherlands)
• Becton, Dickinson and Company (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Reverse Transcriptase in each application, can be divided into

• PCR
• Sequencing
• Cloning

Contents

United States Reverse Transcriptase Market Report 2016

1 REVERSE TRANSCRIPTASE OVERVIEW

1.1 Product Overview and Scope of Reverse Transcriptase
1.2 Classification of Reverse Transcriptase
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Reverse Transcriptase
  1.3.1 PCR
  1.3.2 Sequencing
  1.3.3 Cloning
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Reverse Transcriptase (2011-2021)
  1.4.1 United States Reverse Transcriptase Sales and Growth Rate (2011-2021)
  1.4.2 United States Reverse Transcriptase Revenue and Growth Rate (2011-2021)

2 UNITED STATES REVERSE TRANSCRIPTASE COMPETITION BY MANUFACTURERS

2.1 United States Reverse Transcriptase Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Reverse Transcriptase Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Reverse Transcriptase Average Price by Manufactures (2015 and 2016)
2.4 Reverse Transcriptase Market Competitive Situation and Trends
  2.4.1 Reverse Transcriptase Market Concentration Rate
  2.4.2 Reverse Transcriptase Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES REVERSE TRANSCRIPTASE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Reverse Transcriptase Sales and Market Share by Type (2011-2016)
3.2 United States Reverse Transcriptase Revenue and Market Share by Type (2011-2016)
3.3 United States Reverse Transcriptase Price by Type (2011-2016)
3.4 United States Reverse Transcriptase Sales Growth Rate by Type (2011-2016)

4 UNITED STATES REVERSE TRANSCRIPTASE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Reverse Transcriptase Sales and Market Share by Application (2011-2016)
4.2 United States Reverse Transcriptase Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES REVERSE TRANSCRIPTASE MANUFACTURERS PROFILES/ANALYSIS

5.1 Thermo Fisher Scientific, Inc. (U.S.)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Reverse Transcriptase Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Thermo Fisher Scientific, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck KGaA (Germany)
  5.2.2 Reverse Transcriptase Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck KGaA (Germany) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 New England Biolabs, Inc. (U.S.)
  5.3.2 Reverse Transcriptase Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 New England Biolabs, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Promega (U.S.)
  5.4.2 Reverse Transcriptase Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Promega (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Illumina, Inc. (U.S.)
  5.5.2 Reverse Transcriptase Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Illumina, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Agilent Technologies, Inc. (U.S.)
  5.6.2 Reverse Transcriptase Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Agilent Technologies, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 F. Hoffmann-la Roche Ltd. (Switzerland)
  5.7.2 Reverse Transcriptase Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 F. Hoffmann-la Roche Ltd. (Switzerland) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Takara Bio Inc. (Japan)
  5.8.2 Reverse Transcriptase Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Takara Bio Inc. (Japan) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 QIAGEN N.V. (The Netherlands)
  5.9.2 Reverse Transcriptase Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 QIAGEN N.V. (The Netherlands) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Becton, Dickinson and Company (U.S.)
  5.10.2 Reverse Transcriptase Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Becton, Dickinson and Company (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 REVERSE TRANSCRIPTASE MANUFACTURING COST ANALYSIS

6.1 Reverse Transcriptase Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Reverse Transcriptase

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Reverse Transcriptase Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Reverse Transcriptase Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES REVERSE TRANSCRIPTASE MARKET FORECAST (2016-2021)

10.1 United States Reverse Transcriptase Sales, Revenue Forecast (2016-2021)
10.2 United States Reverse Transcriptase Sales Forecast by Type (2016-2021)
10.3 United States Reverse Transcriptase Sales Forecast by Application (2016-2021)
10.4 Reverse Transcriptase Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Reverse Transcriptase
Table Classification of Reverse Transcriptase
Figure United States Sales Market Share of Reverse Transcriptase by Type in 2015
Table Application of Reverse Transcriptase
Figure United States Sales Market Share of Reverse Transcriptase by Application in 2015
Figure PCR Examples
Figure Sequencing Examples
Figure Cloning Examples
Figure United States Reverse Transcriptase Sales and Growth Rate (2011-2021)
Figure United States Reverse Transcriptase Revenue and Growth Rate (2011-2021)
Table United States Reverse Transcriptase Sales of Key Manufacturers (2015 and 2016)
Table United States Reverse Transcriptase Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Reverse Transcriptase Sales Share by Manufacturers
Figure 2016 Reverse Transcriptase Sales Share by Manufacturers
Table United States Reverse Transcriptase Revenue by Manufacturers (2015 and 2016)
Table United States Reverse Transcriptase Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Reverse Transcriptase Revenue Share by Manufacturers
Table 2016 United States Reverse Transcriptase Revenue Share by Manufacturers
Table United States Market Reverse Transcriptase Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Reverse Transcriptase Average Price of Key Manufacturers in 2015
Figure Reverse Transcriptase Market Share of Top 3 Manufacturers
Figure Reverse Transcriptase Market Share of Top 5 Manufacturers
Table United States Reverse Transcriptase Sales by Type (2011-2016)
Table United States Reverse Transcriptase Sales Share by Type (2011-2016)
Figure United States Reverse Transcriptase Sales Market Share by Type in 2015
Table United States Reverse Transcriptase Revenue and Market Share by Type (2011-2016)
Table United States Reverse Transcriptase Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Reverse Transcriptase by Type (2011-2016)
Table United States Reverse Transcriptase Price by Type (2011-2016)
Figure United States Reverse Transcriptase Sales Growth Rate by Type (2011-2016)
Table United States Reverse Transcriptase Sales by Application (2011-2016)
Table United States Reverse Transcriptase Sales Market Share by Application (2011-2016)
Figure United States Reverse Transcriptase Sales Market Share by Application in 2015
Table United States Reverse Transcriptase Sales Growth Rate by Application (2011-2016)
Figure United States Reverse Transcriptase Sales Growth Rate by Application (2011-2016)
Table Thermo Fisher Scientific, Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific, Inc. (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGaA (Germany) Reverse Transcriptase Sales Market Share (2011-2016)
Table New England Biolabs, Inc. (U.S.) Basic Information List
Table New England Biolabs, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table New England Biolabs, Inc. (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table Promega (U.S.) Basic Information List
Table Promega (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Promega (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Basic Information List
Table Agilent Technologies, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-la Roche Ltd. (Switzerland) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Reverse Transcriptase Sales Market Share (2011-2016)
Table Takara Bio Inc. (Japan) Basic Information List
Table Takara Bio Inc. (Japan) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takara Bio Inc. (Japan) Reverse Transcriptase Sales Market Share (2011-2016)
Table QIAGEN N.V. (The Netherlands) Basic Information List
Table QIAGEN N.V. (The Netherlands) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table QIAGEN N.V. (The Netherlands) Reverse Transcriptase Sales Market Share (2011-2016)
Table Becton, Dickinson and Company (U.S.) Basic Information List
Table Becton, Dickinson and Company (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Becton, Dickinson and Company (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Reverse Transcriptase
Figure Manufacturing Process Analysis of Reverse Transcriptase
Figure Reverse Transcriptase Industrial Chain Analysis
Table Raw Materials Sources of Reverse Transcriptase Major Manufacturers in 2015
Table Major Buyers of Reverse Transcriptase
Table Distributors/Traders List
Figure United States Reverse Transcriptase Production and Growth Rate Forecast (2016-2021)
Figure United States Reverse Transcriptase Revenue and Growth Rate Forecast (2016-2021)
Table United States Reverse Transcriptase Production Forecast by Type (2016-2021)
Table United States Reverse Transcriptase Consumption Forecast by Application (2016-2021)